Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-06 Purchase |
2020-11-10 4:25 pm |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Chief Executive Officer 10% Owner |
14,071,856 | $3.34 | $46,999,999 | 56,296,533 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-29 Exercise |
2020-12-30 9:11 pm |
N/A N/A |
Pulse Biosciences Inc. | PLSE | DUGGAN ROBERT W Director 10% Owner |
384,279 | $7.01 | 11,989,800 (Direct) |
View |
| 2020-12-29 Exercise |
2020-12-30 9:11 pm |
2020-06-15 2025-06-15 |
Pulse Biosciences Inc. | PLSE | DUGGAN ROBERT W Director 10% Owner |
384,279 | $0 | 11,989,800 (Direct) |
View |
| 2020-10-02 Option Award |
2020-10-06 7:42 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Chief Executive Officer 10% Owner |
9,730,539 | $0 | 51,955,216 (Direct) |
View |
Ownership |
2020-09-18 4:17 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W See Remarks 10% Owner |
0 | $0 | 46,209,732 (Direct) |
View |
| 2020-06-15 Exercise |
2020-06-17 4:03 pm |
N/A N/A |
Pulse Biosciences Inc. | PLSE | DUGGAN ROBERT W Director 10% Owner |
2,561,873 | $7.01 | 11,989,800 (Direct) |
View |